Incannex Healthcare (IXHL) Cash from Operations (2023 - 2026)
Incannex Healthcare (IXHL) posted Cash from Operations of 2441000.0 for Q1 2026, up 46.93% sequentially from 4600000.0 in Q4 2025, and up 22.04% YoY from 2000201.78 in Q1 2025.
Incannex Healthcare (IXHL) Cash from Operations (2023 - 2026) Analysis & Trends
Incannex Healthcare has reported Cash from Operations for 4 years, with the latest figure at 2441000.0 in Q1 2026.
- Quarterly Cash from Operations rose 22.04% year-over-year to 2441000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17723000.0 (down 20.79% YoY) and the FY2025 annual result came in at 12513000.0, up 21.03% from the prior year.
- Cash from Operations climbed to 2441000.0 in Q1 2026 per IXHL's latest filing, from 4600000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 1482000.0 in Q2 2025 and troughed at 9200000.0 in Q3 2025.
- A 4-year average of 3839307.69 and a median of 3131000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations surged 60.95% in 2024, then slumped 309.8% in 2025.
- Over 4 years, Cash from Operations stood at 2103000.0 in 2023, then plunged by 168.9% to 5655000.0 in 2024, then rose by 18.66% to 4600000.0 in 2025, then soared by 46.93% to 2441000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 2441000.0, 4600000.0, and 9200000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - | -2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.44 Mn |
| Mar 31, 2026 | -2.44 Mn |
| Dec 31, 2025 | -4.60 Mn |
| Dec 31, 2025 | -4.60 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | -3.13 Mn |
| Mar 31, 2025 | -3.13 Mn |
| Dec 31, 2024 | -5.66 Mn |
| Dec 31, 2024 | -5.66 Mn |
| Sep 30, 2024 | -2.25 Mn |
| Sep 30, 2024 | -2.25 Mn |
| Jun 30, 2024 | -3.64 Mn |
| Jun 30, 2024 | -3.64 Mn |
| Mar 31, 2024 | -4.35 Mn |
| Mar 31, 2024 | -4.35 Mn |
| Dec 31, 2023 | -2.10 Mn |
| Dec 31, 2023 | -2.10 Mn |